Related Experiment Video
Updated: Apr 30, 2026

08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.1K
[MUC4 research progress in tumor molecular markers]
Summary
Mucin antigen 4 (MUC4) shows promise as a tumor marker for early diagnosis and targeted therapy. Further research into MUC4 molecular imaging is needed to advance tumor detection and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biomedical Imaging
Background:
- Mucin antigen 4 (MUC4) is recognized as a significant molecular marker in various malignant tumors.
- MUC4 plays a crucial role in early tumor diagnosis, prognosis assessment, and the development of targeted therapeutic strategies.
- Existing research extensively covers the basic and clinical aspects of MUC4, highlighting its diagnostic and therapeutic potential.
Purpose of the Study:
- To review recent advancements in basic and clinical research concerning MUC4.
- To identify the gap in molecular imaging studies related to MUC4.
- To stimulate further research and development in MUC4-based tumor molecular imaging.
Main Methods:
- Comprehensive literature review of MUC4 research.
- Analysis of existing studies on MUC4's role in oncology.
- Identification of research trends and knowledge gaps in MUC4 molecular imaging.
Main Results:
- MUC4 is a valuable biomarker with broad applications in oncology.
- There is a notable scarcity of reported studies focusing on the molecular imaging of MUC4.
- The review consolidates current knowledge, emphasizing the need for imaging-based research.
Conclusions:
- MUC4 holds significant potential for improving early tumor diagnosis, prognosis, and targeted therapy.
- The limited research in MUC4 molecular imaging presents an opportunity for innovation.
- This review aims to catalyze progress in the field of tumor molecular imaging by focusing on MUC4.

